...
首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy.
【24h】

Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy.

机译:在光动力疗法中开发微乳液以局部递送5-氨基乙酰丙酸。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to obtain and to characterize microemulsions containing 5-aminolevulinic acid (5-ALA) and to investigate the influence of these systems in drug skin permeation for further topical photodynamic therapy (PDT). 5-ALA was incorporated in water-in-oil (W/O), bicontinuous (Bc), and oil-in-water (O/W) microemulsions obtained by the titration of ethyl oleate and PEG-8 caprylic/capric glycerides:polyglyceryl-6 dioleate (3:1) mixtures with water. Selected systems were characterized by conductivity, viscosity, size of the droplets, and drug release. The stability of the drug in the microemulsions was also assessed. Moreover, the in vitro and in vivo skin permeation of 5-ALA was investigated using diffusion cells and confocal scanning laser microscopy (CSLM), respectively. Despite the fact that the O/W microemulsion decreased the 5-ALA diffusion coefficient and retarded the drug release, it also significantly increased the in vitro drug skin permeation when compared to other 5-ALA carriers. It was observed by CSLM that the red fluorescence of the skin increased homogeneously in the deeper skin layers when the 5-ALA microemulsion was applied in vivo, probably due to the formation of the photoactive protoporphyrin IX. The microemulsion developed carried 5-ALA to the deeper skin layers, increasing the red fluorescence of the skin and indicating the potentiality of the system for topical 5-ALA-PDT.
机译:这项研究的目的是获得并表征包含5-氨基乙酰丙酸(5-ALA)的微乳状液,并研究这些系统在药物皮肤渗透中对进一步局部光动力疗法(PDT)的影响。将5-ALA掺入通过滴定油酸乙酯和PEG-8辛酸/癸酸甘油酯获得的油包水(W / O),双连续(Bc)和水包油(O / W)微乳液中:聚甘油-6二油酸酯(3:1)与水的混合物。所选系统的特点是电导率,粘度,液滴大小和药物释放。还评估了药物在微乳液中的稳定性。此外,分别使用扩散池和共聚焦扫描激光显微镜(CSLM)研究了5-ALA的体外和体内皮肤渗透。尽管O / W微乳降低了5-ALA扩散系数并延迟了药物释放,但与其他5-ALA载体相比,它也显着提高了体外药物皮肤的渗透性。通过CSLM观察到,当在体内施用5-ALA微乳剂时,皮肤的红色荧光在较深的皮肤层中均匀地增加,这可能是由于光活性原卟啉IX的形成。所开发的微乳液将5-ALA带到更深的皮肤层,增加了皮肤的红色荧光,表明该系统具有局部5-ALA-PDT的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号